Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levcromakalim effects on cerebral hemodynamics in migraine
NCT03228355Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- May 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levcromakalim (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoints: Cerebral hemodynamic, Headache and 1 more. Started May 2017; status: completed.
02
Drugs
levcromakalim
Beyond the preview
Go deeper on NCT03228355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03228355.